¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"delayed graft"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cable graft
    Àü¼±À̽Ä
  • cadaver graft
    ½ÃüÀÌ½ÄÆí
  • cantilever bone graft
    µé¸²»ÀÀ̽Ä
  • collagen graft
    ¾Æ±³ÁúÀ̽Ä
  • composite graft
    º¹ÇÕÀ̽Ä, º¹ÇÕÁ¶Á÷À̽Ä
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ¼ú, ½ÉÀ嵿¸Æ¿ìȸ¼ú
  • costal cartilage graft
    °¥ºñ¿¬°ñÀ̽Ä, ´Á¿¬°ñÀ̽Ä
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷À̽Ä
  • cartilage graft
    ¿¬°ñÀÌ½ÄÆí
  • chorioallantoic graft
    À¶¸ð¿ä¸·À̽Ä
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • free graft
    À¯¸®ÀÌ½ÄÆí
  • free jejunal graft
    À¯¸®ºóâÀÚÀ̽Ä(¼ú), À¯¸®°øÀåÀ̽Ä(¼ú)
  • full-thickness graft
    ÀüÃþÇǺÎÀ̽Ä
  • gauntlet graft
    Àå°©¸ð¾çÀ̽İñÆí
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • autodermic graft
    ÀÚ°¡ÇǺÎÀ̽Ä
  • autogenous bone graft
    ÀÚ±â»ÀÀ̽Ä, ÀÚ°¡°ñÀ̽Ä
  • graft atherosclerosis
    ÀÌ½ÄÆíÁ×»ó°æÈ­Áõ
  • bone graft
    »ÀÀ̽Ä, °ñÀ̽Ä
  • bridging graft
    ±³·®À̽Ä
  • bypass graft
    ¿ìȸ·ÎÁ¶¼º¼ú, ¿ìȸ¼ú
  • cable graft
    Àü¼±À̽Ä
  • cantilever bone graft
    µé¸²»ÀÀ̽Ä
  • chorioallantoic graft
    À¶¸ð¿ä¸·À̽Ä
  • collagen graft
    ¾Æ±³ÁúÀ̽Ä
  • composite graft
    º¹ÇÕÀ̽Ä, º¹ÇÕÁ¶Á÷À̽Ä
  • coronary artery bypass graft
    ½ÉÀ嵿¸Æ¿ìȸ¼ú
  • costal cartilage graft
    °¥ºñ¿¬°ñÀ̽Ä, ´Á¿¬°ñÀ̽Ä
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷À̽Ä
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • homoplastic graft =isoplastic g.
    µ¿Á¾ÀÌ½ÄÆí(¡­ì¹ãÕø¸).
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(Áõ½Ä¼ºÀÌ½ÄÆí).
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(ñòãÖàõì¹ãÖø¸).
  • inlay bone graft
    ³»Àç °ñ À̽Ä(Ò®î¤Íéì¹ãÕ), °¨ÀÔ °ñ À̽Ä(ÊîìýÍéì¹ãÕ).
  • inlay graft
    Àη¹ÀÌ À̽Ä.
  • pinch graft
    ¼ÒÆí½ÄÇǼú(¼ÒÆí½ÄÇǼú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • delayed symptom
    Áö¿¬Áõ»ó(òÀæÅñøßÒ).
  • delayed type hypersensitivity
  • delayed union
    Áö¿¬À¯ÇÕ(òÀæÅë¨ùê).
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • partus serotinus =delayed labor ³ª
    Áö¿¬ºÐ¸¸
  • phase-delayed sleep
    »óÁö¿¬¼ö¸é(ßÓòÀæÅâ²Øù)
  • test, delayed feedback
    Áö¿¬Àç»ý°Ë»ç
  • test, delayed side tone [=DSTT]
    ¿Ï¼Ó¾îÀ½ ûÃë°Ë»ç(¹ý) èÐáÜåÞëå
  • alloplastic graft
    ¹«»ý¹°Àç·áÀÌ½ÄÆí(ÙíßæÚªî§è÷ì¹ãÕø¸).
  • animal graft
    µ¿¹°½ÄÇÇ(¡­½ÄÇÇ).
  • artificial skin graft
    Àΰø ÇǺÎÀ̽Ä
  • autodermic graft
    ÀÚ°¡½ÄÇÇÆí(í»Ê«ãÕù«ø¸).
  • autogenous bone graft
    ÀÚ°¡°ñ À̽Ä(¼ú)(í»Ê«Íéì¹ãÖâú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
DPC delayed primary closure; desaturated phosphatidylcholine; diethylpyrocarbonate; direct patient care;...
DPS delayed primary suture; descending perineum syndrome; dimethylpolysiloxane; dysesthetic pain syndrom...
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
DSHR delayed skin hypersensitivity reaction
DSP decreased sensory perception; delayed sleep phase; desmoplakin; dibasic sodium phosphate; digital si...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
GVL Graft vs leukemia
GIC Graft-infiltrating cells
GIL Graft-infiltrating lymphocytes
GVH Graft-versus-host disease
GvH Graft-vs-Host
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • osteoperiosteal graft
    °ñ¸· À̽Ä
  • patch graft
    øºÎ ÀÌ½ÄÆí
    Ç÷°ü°­À» È®´ëÇϱâ À§ÇÏ¿© Ç÷°ü Àý°³ºÎ¸¦ ¸·´Â µ¥ »ç¿ëµÇ´Â À̽Ŀë Á¶Á÷ ¶Ç´Â ÀÎÁ¶ ¹°Áú.
  • pedicle graft
    °æ»ó ÀÌ½ÄÆí
  • penetrating graft
    °üÅë À̽Ä
    °¢¸·ÀÇ ÀüÃþ À̽Ä.
  • perichondral bony ring

    perichondral cutaneous graft

    ¿¬°ñ¸· ÇǺΠÀ̽Ä
  • periosteal graft
    °ñ¸· À̽Ä, °ñ¸· ÀÌ½ÄÆí
    °ñÀÇ ¹þ°ÜÁø ºÎÀ§¿¡ »ç¿ëµÇ´Â °ñ¸·Æí.
  • Phemister graft
    Æä¹Ì½ºÅÍ À̽Ä
    ÇÇÁú°ñ ÀÌ½Ä ½Ã¿¡ ÇØ¸é ¼¼Á°ñ À̽ÄÀ» °°ÀÌÇÏ¸é °¡°ñ Çü¼ºÀÌ ÀߵȴÙ.
  • pinch graft
    ÇÉÄ¡ À̽Ä
    Á÷°æ 0.25ÀÎÄ¡ÀÇ ÇÇºÎÆí. ħÀ¸·Î ÇǺθ¦ µé¾î¿Ã·Á Ä®·Î ¾ã°Ô Àß¶ó¼­ ¾ò´Â´Ù. µÎ²²´Â ÀÌ½ÄÆí¸¶´Ù ´Ù¸£³ª Áö¹æÀº ºÙ¾îÀÖÁö ¾Ê´Ù.
  • sieve graft
    »ç»ó À̽Ä
    ¿øÇüÀÇ ¾ÆÁÖ ÀÛÀº ¸î °³ÀÇ µµ°¡ Á¦°ÅµÈ ÇǺΠÀÌ½ÄÆí. ÀÌ´Â Å« ³ëÃâµÈ ºÎÀ§¸¦ µ¤´Âµ¥ »ç¿ëµÈ´Ù.
  • skin graft thickness
    ÀüÃþ ÇǺΠÀÌ½ÄÆí
  • split skin graft
    ºÎºÐÃþ ½ÄÇǼú
  • split thickness skin graft
    ºÎºÐ Ãþ ÇǺΠÀ̽Ä
  • Thierschs skin graft
    Ƽ¸£½´ ÇǺΠÀ̽ļú
  • xenogenic graft
    ÀÌÁ¾À̽Ä
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ÄÇÏ´Â °Í.
  • xenogenous graft
    ÀÌÁ¾ ÀÌ½ÄÆí
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ĵǴ ½ÃÆí.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
graft-versus-host disease <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host reaction <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host response <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
mesh graft A skin graft in which multiple slits have been made, so it can be stretched to cover a large area.
Synonym: mesh graft.
(05 Mar 2000)
periosteal graft A graft of periosteum, usually placed on bare bone.
(05 Mar 2000)
chip graft A graft utilizing small pieces of cartilage or bone which is packed into a bone defect.
(05 Mar 2000)
chorioallantoic graft Transplanting of living material to the chorioallantoic membrane of the embryonic chick.
(05 Mar 2000)
Phemister graft An autogenous onlay bone graft used in treating delayed union of fractures.
(05 Mar 2000)
pinch graft Small bits of skin, of partial or full thickness, removed from a healthy area and seeded in a site to be covered.
Synonym: Reverdin graft.
(05 Mar 2000)
white graft Rejection of a skin allograft so acute that vascularization never occurs.
(05 Mar 2000)
composite graft A graft composed of several structures, such as skin and cartilage or a full-thickness segment of the ear.
(05 Mar 2000)
mucosal graft A graft of mucous membrane, usually the full-thickness of the lining of the cheek or lower lip.
(05 Mar 2000)
Wolfe graft A full-thickness skin graft without any subcutaneous fat.
Synonym: Wolfe-Krause graft.
(05 Mar 2000)
Wolfe-Krause graft A full-thickness skin graft without any subcutaneous fat.
Synonym: Wolfe-Krause graft.
(05 Mar 2000)
corneal graft corneal transplant
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á